Men's HealthAsad K. Niazi, MD, MPH
Board Certification
Internal Medicine (ABIM)
Alma Mater
Texas Tech University – Foster School of Medicine
Weight Loss
Weekly injection
First order: $110
Second and subsequent refills $160 per 30-day supply of medication or from $329 for a 90-day supply of medication. Automatic refills – pause, delay or cancel anytime – just make those changes at least 48 hours before your next refill date.
Proven, weekly, and dosed around your schedule.
Start
Answer a few questions about your health and goals.
⏱ 5-10 minutes
Review
They decide whether treatment is appropriate. No video visit required in 41 states.
⏱ <4 business hours
Delivered
One of our trusted pharmacy partners discreetly ships your medication to your doorstep.
⏱ <1 week*
*Timelines shown reflect our average turnaround times and are not guaranteed.
4.8 average. Patients love us. And we work hard to earn it.
Men's HealthBoard Certification
Internal Medicine (ABIM)
Alma Mater
Texas Tech University – Foster School of Medicine
LongevityBoard Certification
Family Medicine (ABFM)
Alma Mater
Xavier University School of Medicine
LongevityBoard Certification
Family Medicine (ABFM)
Alma Mater
Xavier University School of Medicine
Men's HealthBoard Certification
Physical Medicine and Rehabilitation (ABPMR)
Alma Mater
Lake Erie College of Osteopathic Medicine
Oversight
Physician reviewed
Dose
Semaglutide is administered as a once-weekly subcutaneous injection.
Frequency
Weekly injection
Included
Medication, supplies, expedited shipping
*Compounded versions of semaglutide are not associated with Novo Nordisk and/or its genuine OZEMPIC® and/or WEGOVY® products. Compounded versions of semaglutide are not FDA approved, and neither the FDA nor any global regulatory agency has reviewed these products for safety, quality, or efficacy. GLP-1 medications may cause serious side effects, including possible thyroid tumors, including cancer. See the "Safety Information" links below for more details.
1 Wilding JPH, et al. STEP 1: Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002.




